Hosted on MSN4mon
Some diabetes meds might lower risk of dementia, Parkinson's
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, also known as gliflozins, lower blood sugar by prompting the kidneys to filter sugar out of the bloodstream and excrete it in urine, researchers ...
Hosted on MSN6mon
Combined use of popular diabetes drugs likely to offer additional protection against heart and kidney disease
SGLT2is, also called gliflozins, are a class of drug that lower ... Researchers involved in the SGLT2 Inhibitor Meta-analysis Cardio-Renal Trialists' Consortium (SMART-C) pooled data across ...
Medscape2d
The Role of Kidney in Glucose Homeostasis — SGLT2 Inhibitors, a New Approach in Diabetes Treatment
SGLT2 inhibitors are a new family of agents, which occlude the path of SGLT2 glucose reabsorption and cause glucosuria. Efficacy of SGLT2 inhibitors includes reduction of HbA1c, fasting and ...
Medscape17d
Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition
Objective Sodium–glucose cotransporter 2 (SGLT-2) inhibitors are the most recently approved antihyperglycemic medications. We sought to describe their association with euglycemic diabetic ...
Healio21d
SGLT2 inhibitors may improve kidney outcomes for Asian adults with type 2 diabetes
If you continue to have this issue please contact [email protected]. Starting SGLT2 inhibitors led to a lower risk of eGFR decline or incident kidney failure. SGLT2 inhibitors were also ...